Enhancing the dissolution of phenylbutazone using Syloid® based mesoporous silicas for oral equine applications

Three mesoporous silica excipients (Syloid® silicas AL-1 FP, XDP 3050 and XDP 3150) were formulated with a model drug known for its poor aqueous solubility, namely phenylbutazone, in an attempt to enhance the extent and rate of drug dissolution. Although other forms of mesoporous silica have been in...

Full description

Saved in:
Bibliographic Details
Main Authors: Laura J. Waters (Author), John P. Hanrahan (Author), Joseph M. Tobin (Author), Catherine V. Finch (Author), Gareth M.B. Parkes (Author), Shamsuddeen A. Ahmad (Author), Faraj Mohammad (Author), Maria Saleem (Author)
Format: Book
Published: Elsevier, 2018-06-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available